BDBM487971 4-(4-((5-chloro-2-methyl-6-(2H- 1,2,3-triazol-2-yl)pyridin-3- yl)carbamoyl)-5- (trifluoromethyl)-1H-pyrazol-1- yl)thieno[2,3-c]pyridine-7- carboxamide::US10954214, Compound 393
SMILES: Cc1nc(c(Cl)cc1NC(=O)c1cnn(c1C(F)(F)F)-c1cnc(C(N)=O)c2sccc12)-n1nccn1
InChI Key: InChIKey=SFWKTIMVKFWOKX-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (Homo sapiens (Human)) | BDBM487971![]() (4-(4-((5-chloro-2-methyl-6-(2H- 1,2,3-triazol-2-yl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description MALT1 protease activity was assessed in an in vitro assay using a tetrapeptide as substrate and full-length MALT1 protein (Strep-MALT1(1-824)-His) pu... | US Patent US10954214 (2021) | |||||||||||
More data for this Ligand-Target Pair |